Glucose intolerance, abnormal cholesterol level, high blood pressure, and upper body obesity are characteristics of

Glucose intolerance, abnormal cholesterol level, high blood pressure, and upper body obesity are characteristics of

• A. Insulin resistance
• B. Chronic inflammatory disease
• C. Coronary heart disease
• D. Cerebrovascular disease

Answer: (A)

These features together point to insulin resistance, the metabolic pattern behind metabolic syndrome. When cells don’t respond well to insulin, several interconnected problems arise. Glucose intolerance reflects the body’s struggle to handle blood sugar because insulin signaling is impaired. Dyslipidemia typically appears as higher triglycerides and lower HDL cholesterol, a direct consequence of altered lipid processing in the setting of insulin resistance. Hypertension develops partly from mechanisms like increased sodium retention and vascular changes driven by insulin resistance and adipose tissue signals. Central (upper body) obesity is both a marker and contributor, since abdominal fat tends to worsen insulin sensitivity and promotes inflammatory mediators that aggravate metabolic abnormalities. Together, these four findings describe the insulin-resistance/metabolic-syndrome pattern, rather than being a single disease like chronic inflammatory disease or an established cardiovascular condition. Coronary heart disease or cerebrovascular disease may result from this syndrome over time, but they are complications rather than the defining characteristics.

These features together point to insulin resistance, the metabolic pattern behind metabolic syndrome. When cells don’t respond well to insulin, several interconnected problems arise. Glucose intolerance reflects the body’s struggle to handle blood sugar because insulin signaling is impaired. Dyslipidemia typically appears as higher triglycerides and lower HDL cholesterol, a direct consequence of altered lipid processing in the setting of insulin resistance. Hypertension develops partly from mechanisms like increased sodium retention and vascular changes driven by insulin resistance and adipose tissue signals. Central (upper body) obesity is both a marker and contributor, since abdominal fat tends to worsen insulin sensitivity and promotes inflammatory mediators that aggravate metabolic abnormalities. Together, these four findings describe the insulin-resistance/metabolic-syndrome pattern, rather than being a single disease like chronic inflammatory disease or an established cardiovascular condition. Coronary heart disease or cerebrovascular disease may result from this syndrome over time, but they are complications rather than the defining characteristics.